BMP-7 variant compositions, methods and uses

Details BMP-7 variant compositions, methods and uses BMP-7 variant compositions, methods and uses

2007-06-08

2010-02-09

Kremmerer, Elizabeth C. (Department: 1646)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

C514S002600, C514S007600, C514S008100, C530S350000

Reexamination Certificate

active

07659250

ABSTRACT:
Human Bone Morphogenic Protein 7 (hBMP-7) variant peptide chains, nucleic acids encoding these peptide chains, and methods of making and using the foregoing are disclosed.

REFERENCES:
patent: 5194596 (1993-03-01), Tischer et al.
patent: 5350836 (1994-09-01), Kopchick et al.
patent: 2002/0028453 (2002-03-01), Keck et al.
patent: 2005/0114037 (2005-05-01), Desjarlais et al.
patent: 2005/0255141 (2005-11-01), Oppermann et al.
patent: WO 94/03600 (1994-02-01), None
patent: WO 99/03887 (1999-01-01), None
patent: WO 99/37320 (1999-07-01), None
patent: WO 00/20591 (2000-04-01), None
patent: WO 00/20607 (2000-04-01), None
patent: WO 2005/097825 (2005-10-01), None
Vukicevic et al., 1996, PNAS USA 93:9021-9026.
Massague, 1987, Cell 49:437-438.
Benjamin et al., 1998, Development 125:1591-1598.
Pilbeam et al., 1993, Bone 14:717-720.
Skolnick et al., 2000, Trends in Biotech. 18:34-39.
Bork, 2000, Genome Research 10:398-400.
Doerks et al., 1998, Trends in Genetics 14:248-250.
Smith et al., 1997, Nature Biotechnology 15:1222-1223.
Brenner, 1999, Trends in Genetics 15:132-133.
Bork et al., 1996, Trends in Genetics 12:425-427.
Wells, 1990, Biochemistry 29:8509-8517.
Ngo et al., 1994, The Protein Folding Problem and Tertiary Structure Prediction, Merz et al., eds., Birkhauser, Boston, pp. 492-495.
Gregory, et al., “The prodomain of BMP-7 targets the BMP-7 complex to the extracellular matrix,” Journal of Biological Chemistry, 280(30): 27970-27980(2005). GenBank Accession No. NP 001710 (Jun. 11, 2005).
Greenwald, et al., “The BMP7/ActRII Extracellular Domain Complex Provides New Insights into the Cooperative Nature of Receptor Assembly,” Molecular Cell, 11: 605-617 (2003).
Griffith, et al., “Three-dimensional structure of recombinant human osteogenic protein 1: Structural paradigm for the transforming growth factor β superfamily,” Proceedings of the National Academy of Science USA, 93: 878-883 (1996).
Keller, et al., “Molecular recognition of BMP-2 and BMP receptor IA,” Nature Structural & Molecular Biology, 11(5): 481-488 (2004).
Groppe, et al., “Structural basis of BMP signaling inhibition by the cystine knot protein Noggin,” Nature, 420: 636-642 (2002).
Özkaynak, et al., “OP-1 cDNA encodes an osteogenic protein in the TGF-β family,” The EMBO Journal, 9(7): 2085-2093 (1990).
Saulo Klahr, “The bone morphogenetic proteins (BMPs). Their role in renal fibrosis and renal function,” Journal of Nephrology, 16: 179-185 (2003).
PCT International Search Report dated Aug. 8, 2008.
Supplemental EP Search Report dated Apr. 8, 2009.

Affiliated with

Also associated with

Rating

BMP-7 variant compositions, methods and uses does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with BMP-7 variant compositions, methods and uses, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and BMP-7 variant compositions, methods and uses will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4226917